BRIEF: Leading RNA drug developer Ribo passes Hong Kong listing hearing, kicking off IPO
Leading RNA drug developer Suzhou Ribo Life Science Co. Ltd. passed its hearing for a listing on the Hong Kong Stock Exchange, marking the official launch of its IPO, according…
BRIEF: Bao Pharma doubles in Hong Kong trading debut
Shares Shanghai Bao Pharmaceuticals Co. Ltd. (2659.HK) opened up 128% in their Hong Kong trading debut on Wednesday, and held on to the gains during the morning session to close…
BRIEF: InSilico gets CSRC nod for Hong Kong IPO
AI drug discovery platform InSilico Medicine Cayman TopCo has been approved by China’s securities watchdog for a Hong Kong IPO, clearing a key hurdle in its stalled listing. According to…
BRIEF: Wai Yuen Tong’s profit plunges in first half of fiscal year
Drug and healthcare products maker Wai Yuen Tong Medicine Holdings Ltd. (0897.HK) warned on Monday that it expects to report its profit plunged 87% year-on-year to HK$3 million ($390,000) or…
BRIEF: Haixi Pharma delays IPO trading debut
Fujian Haixi Pharmaceuticals Co. Ltd. (2637.HK) said on Thursday night that the trading debut for its Hong Kong IPO, originally scheduled for Friday, will be postponed. It blamed the delay…
BRIEF: Xuanzhu Biopharma launches IPO to raise $100 million
Xuanzhu Biopharmaceutical Co., Ltd. (2575.HK), spun off from Sihuan Pharma (0460.HK), launched its IPO on Monday, aiming to sell 67.3 million shares for HK$11.60 each to raise HK$780 million ($100…
BRIEF: Baiyunshan invests $105 million for 11% of NanJing Pharma
Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. (0874.HK; 600332.SH) said on Sunday it paid 749 million yuan ($105 million) via its Guangzhou GP Fund II subsidiary for 11.04% of NanJing Pharmaceutical…
Recent Articles
RELATED ARTICLES
-
BRIEF: Butong passes listing hearing, targets IPO launch by month’s end
- BRIEF: Guoxia Technology clears Hong Kong listing hearing
- BRIEF: Nuobikan clears Hong Kong listing hearing
- Obesity drug maker Sciwind targets IPO, with heavyweight backers
-
BRIEF: Robot developer Yunji Tech to raise $85 million in Hong Kong IPO
2670.HK
-
CSPC feels the pain from sweeping cuts in drug prices
1093.HK
- Ming Yu seeks a share of the drug sector limelight
